Investigation of Three Biomarkers for the Detection of Prostate Cancer
Recruiting
Observational Study
Cancer of Prostate
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 137 (estimated)
- Sponsor
- Medtechtomarket Consulting Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
GlycoScore Dx Limited, a diagnostics company based in the United Kingdom have identified three glycoproteins, that showed promise as biomarkers of prostate cancer in initial validation studies. The purpose of this study is to further evaluate the sensitivity and specificity of the GlycoScore biomarkers for the detection of clinically significant prostate cancer. Sensitivity and specificity will be…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male patients aged 18 years and over
* The patient is being investigated for suspected prostate cancer or is on active surveillance
* The patient is able to give consent to take part in the study
Exclusion Criteria:
* A patient who has already taken part in the study
* A pat…
Contacts